1. Home
  2. CYPH vs OPXS Comparison

CYPH vs OPXS Comparison

Compare CYPH & OPXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CYPH

Cypherpunk Technologies Inc.

N/A

Current Price

$0.76

Market Cap

73.4M

Sector

Health Care

ML Signal

N/A

Logo Optex Systems Holdings Inc.

OPXS

Optex Systems Holdings Inc.

HOLD

Current Price

$12.63

Market Cap

84.8M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYPH
OPXS
Founded
2011
1987
Country
United States
United States
Employees
6
72
Industry
Biotechnology: Pharmaceutical Preparations
Electronic Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
73.4M
84.8M
IPO Year
N/A
2009

Fundamental Metrics

Financial Performance
Metric
CYPH
OPXS
Price
$0.76
$12.63
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$16.10
AVG Volume (30 Days)
6.8M
39.7K
Earning Date
05-13-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
34.55
EPS
N/A
0.23
Revenue
N/A
$24,530,000.00
Revenue This Year
N/A
$39.17
Revenue Next Year
N/A
$0.53
P/E Ratio
N/A
$53.39
Revenue Growth
N/A
17.63
52 Week Low
$0.49
$9.74
52 Week High
$3.70
$17.76

Technical Indicators

Market Signals
Indicator
CYPH
OPXS
Relative Strength Index (RSI) 43.75 55.63
Support Level $0.54 $12.52
Resistance Level $0.79 $13.68
Average True Range (ATR) 0.11 0.83
MACD -0.02 0.04
Stochastic Oscillator 31.82 56.27

Price Performance

Historical Comparison
CYPH
OPXS

About CYPH Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.

About OPXS Optex Systems Holdings Inc.

Optex Systems Holdings Inc manufactures optical sighting systems and assemblies for the U.S. Department of Defense, foreign military applications, and commercial markets. Its products are installed on a variety of United States military land vehicles, such as the Abrams and Bradley fighting vehicles, light armored and security vehicles, and have been selected for installation on the Stryker family of vehicles. The company's operating segment includes Optex Systems Richardson, Applied Optics Center Dallas, and others. It generates maximum revenue from the Optex Systems Richardson segment. Some of its products include M17 Day/Thermal Periscope; DDAN / M36 Sights; Laser Protected Periscopes; Muzzle Reference Sensor, and others.

Share on Social Networks: